Turčić, Ana http://orcid.org/0000-0001-8138-4170
Knežević, Josip
Zaninović, Ljiljana
Habek, Mario
Skorić, Magdalena Krbot
Babić, Antonija
Vogrinc, Željka
Article History
Received: 14 December 2023
Accepted: 24 June 2024
First Online: 3 August 2024
Declarations
:
: The study was approved by the institution’s Ethical Committee (approval No. 8.1–23/69 − 2).
: M.H. participated as a clinical investigator and/or received consultation and/or speaker fees from: Biogen, Sanofi Genzyme, Merck, Bayer, Novartis, Pliva/Teva, Roche, Alvogen, Actelion, Alexion Pharmaceuticals, TG Pharmaceuticals. MKS received speaker fees from Sanofi Genzyme and Roche. The other authors declare no conflict of interest.